is a permanent researcher at the French National Center for Scientific Research (CNRS) in the team “Neuroproteomics and Signalling of Brain Disorders” of the Institute for Functional Genomics (IGF, Montpellier, France).

He leads projects aiming at decrypting the fine modulation by phosphorylation and protein-protein interactions of GPCRs targeted by antipsychotics, namely serotonin 2A receptors and metabotropic glutamate receptor 2.

With numerous articles which include proteomic experiments, he has a great experience in the characterization of protein complexes and post translational modifications using affinity purification coupled to mass spectrometry.

In 2020, he was elected President of the French Proteomics Society (FPS, https://www.french-proteomics-society.fr).

ORCID ID